956 resultados para Gardiner, Robert Barlow, 1843-
Resumo:
Mode of access: Internet.
Resumo:
Contains brief notices of the Hallowell, Gardiner, Vaughan, Dumaresq and Tudor families.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Contiene: Vol. 1 (XII, 352 p.) - Vol. 2 (VII, 360 p.) - Vol. 3 (VIII, 352 p.) - Vol. 4 (VIII, 390 p.) - Vol. 5 (VIII, 368 p.) - Vol. 6 (VIII, 408 p.)
Resumo:
Added t.-p., engr.
Resumo:
Mode of access: Internet.
Resumo:
Vol. 4 has imprint : Boston, New York, Houghton, Mifflin and company, 1884.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Mode of access: Internet.
Resumo:
Two columns to the page.
Resumo:
Reprint of the author's thesis, Columbia University.
Resumo:
Mode of access: Internet.
Resumo:
First-degree relatives of men with prostate cancer have a higher risk of being diagnosed with prostate cancer than men without a family history. The present review examines the prevalence and predictors of testing in first-degree relatives, perceptions of risk, prostate cancer knowledge and psychological consequences of screening. Medline, PsycInfo and Cinahl databases were searched for articles examining risk perceptions or screening practices of first-degree relatives of men with prostate cancer for the period of 1990 to August 2007. Eighteen studies were eligible for inclusion. First-degree relatives participated in prostate-specific antigen (PSA) testing more and perceived their risk of prostate cancer to be higher than men without a family history. Family history factors (e.g. being an unaffected son rather than an unaffected brother) were consistent predictors of PSA testing. Studies were characterized by sampling biases and a lack of longitudinal assessments. Prospective, longitudinal assessments with well-validated and comprehensive measures are needed to identify factors that cue the uptake of screening and from this develop an evidence base for decision support. Men with a family history may benefit from targeted communication about the risks and benefits of prostate cancer testing that responds to the implications of their heightened risk.